KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Equity (2019 - 2025)

Historic Return on Equity for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to 0.22%.

  • Aurinia Pharmaceuticals' Return on Equity rose 2800.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.02% for FY2024, which is 2100.0% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Return on Equity is 0.22%, which was up 2800.0% from 0.18% recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Return on Equity registered a high of 0.22% during Q3 2025, and its lowest value of 0.6% during Q3 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Return on Equity value was 0.2% (recorded in 2023), while the average stood at 0.19%.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Return on Equity soared by 3300bps in 2022 and then skyrocketed by 500bps in 2024.
  • Aurinia Pharmaceuticals' Return on Equity (Quarter) stood at 0.47% in 2021, then soared by 44bps to 0.26% in 2022, then rose by 22bps to 0.2% in 2023, then soared by 107bps to 0.01% in 2024, then surged by 1390bps to 0.22% in 2025.
  • Its Return on Equity was 0.22% in Q3 2025, compared to 0.18% in Q2 2025 and 0.11% in Q1 2025.